Skip to main content

DNAStar Receives Phase I SBIR Grant to Build Antibody Engineering Software

NEW YORK (GenomeWeb News) — The National Institutes of Health has awarded a Small Business Innovation Research grant to DNAStar to fund the development of software for engineering antibodies.

DNAStar said this week that the tool that it will develop using the funds from the NIH is "a key step" in its ongoing efforts to build a comprehensive desktop proteomics software suite.

In a statement, DNAStar VP and GM Tom Schwei said that the company has for several years been building "a foundation for our emerging proteomics platform in Protean 3D within our Lasergene software suite."

He said that the NIH grant "will help us move quickly to develop a key component of our vision for our proteomics suite — creating a tool to produce superior epitope prediction and antibody engineering results compared to today's available methods and tools."

The company also plans to include tools for protein structure prediction, protein motion, and molecular interactions in its proteomics suite, Schwei said.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.